News updates
-
12 APRFatigue associated with biologics
Fatigue is a common symptom in patients with inflammatory immune diseases. Patients may also experience fatigue as an adverse drug reaction of biologics used for an immune-mediated inflammatory diseas...
Read more -
04 APRInhalation of small capsule pieces through an inhaler is not harmful
Puncturing powder capsules for inhalation may cause small capsule pieces to break loose. Capsule pieces that are small enough to pass through the filter are sometimes inhaled when using the inhaler. ...
Read more -
10 MARGuillain-Barré Syndrome after COVID-19 vaccination
Until October 12th 2022, the Netherlands Pharmacovigilance Centre Lareb received 72 reports of Guillain-Barré Syndrome (GBS) following COVID-19 vaccination. GBS is labeled as a rare side effect of th...
Read more -
15 FEBPropylthiouracil and ANCA vasculitis
The Netherlands Pharmacovigilance Centre Lareb received seven well-documented reports on propylthiouracil and anti-neutrophil cytoplasmic antibody (ANCA) positive vasculitis. Propylthiouracil is an a...
Read more -
13 FEBCall for abstracts for the ISoP Mid-Year Symposium 2023
This year the ISoP mid-year meeting will be hosted by the Netherlands Pharmacovigilance Centre Lareb on 1-2 June 2023 in Leiden, the Netherlands. This meeting will focus on connecting the multiple sci...
Read more -
07 FEBHigher probability of experiencing a side effect in women after COVID-19 vaccination
Females have a two-fold higher odds of experiencing an adverse event following immunization (AEFI) than males after a COVID-19 vaccination. This difference was greater after the first COVID-19 vaccina...
Read more